Table 1. Clinical characteristics of the participants.
Data are expressed as mean ± standard deviation (SD), as number (percentage), or as median (IQR); NSTEMI, non-ST segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction; BTP, beta-trace protein.
| Variable | Study Population (n = 138) |
| Age (years) (mean ±SD) | 66,4±14,0 |
| Gender (%) | |
| Male | 91(65,9%) |
| Female | 47(34,1%) |
| Systolic blood pressure (mm Hg) | 122±23,5 |
| Diastolic blood pressure(mm Hg) | 73,2±12,7 |
| Heart rate (beats/min) | 81,1±16 |
| Glucose (mg/dL) | 113,5(79,2) |
| Diabetes mellitus | 46 (33,3%) |
| Hypertension | 83 (60,1%) |
| Hyperlipidemia | 42(30,4%) |
| Coronary artery disease | 41(29,7%) |
| Habitual smoking | 49(35,5%) |
| Family history | 39(28,3%) |
| Admission BTP (microg/dl) | 589,6 (315,9) |
| Hour 8 BTP (microg/dl) | 619,5 (329,1) |
| Admission creatinine (mg/dL) | 0,9(0,3) |
| Admission urea (mg/dL) | 38,6±13,2 |
| STEMI | 69(50%) |
| NSTEMI | 69(50%) |
| Ejection fraction | 50±12,5 |
| Left ventricular dysfunction | 106(76,8%) |
| Coronary angiography | |
| 1-vessel disease | 60 (%43,4) |
| 2-vessel disease | 21 (%15,2) |
| 3-vessel disease | 34 (%24,6) |
| 30-Day mortality | 10(7,2%) |